Medical Condition News

RSS

Study identifies gaps in primary health care for seniors with multiple chronic conditions

The number of health care services seniors use is determined more by the number of chronic conditions they have than by their age, according to a new study from the Canadian Institute for Health Information.

28 Jan 2011

Study: Running-related injuries increased to 34% in children

Researchers at the Center for Injury Research and Policy of The Research Institute at Nationwide Children's Hospital examined running-related injuries among children and adolescents 6 to 18 years old and found that an estimated 225,344 cases were treated in U.S. emergency departments from 1994 through 2007, for an average of more than 16,000 each year. During the 14-year study period, the annual number of running-related injuries increased 34 percent.

28 Jan 2011

Protein Erk necessary for nerve fibers to be wrapped with myelin

Researchers at the University of North Carolina at Chapel Hill have pinpointed a crucial function for a key player in the development of the nervous system. They found that this player - a protein called Erk - is necessary for nerve fibers to be wrapped with an insulating substance called myelin, which allows messages to be sent from the brain to the peripheral limbs and back again.

28 Jan 2011

Patients and spouses experience distress related to diabetes

Older patients with diabetes who are not dealing well with the disease are likely to have symptoms of depression, and spouses of older patients also suffer distress related to diabetes and its management, according to research from Purdue University.

28 Jan 2011

XYTOS shares cancer patient treatment results

XYTOS Shares Patient Results.

28 Jan 2011

API2-MALT1 fusion protein appears to trigger cancer

What happens when two proteins join together? In this case, they become like a power couple, where the whole is greater than the sum of the parts. API2 and MALT1 are two proteins that become fused together in a subset of lymphomas. The API2 part of the fusion connects with an enzyme called NIK. When it does, MALT1 comes in for the kill, splitting NIK in two, a process called cleavage.

28 Jan 2011

Endo and Orion enter oncology R&D collaboration

Endo Pharmaceuticals announced today that it has entered into a collaboration agreement with European-based Orion Corporation for the discovery, development and commercialization of assets in Oncology.

28 Jan 2011

Single DNA variation linked to decreased risk of coronary disease in African-Americans

A team of scientists at Johns Hopkins and elsewhere has discovered that a single alteration in the genetic code of about a fourth of African-Americans helps protect them from coronary artery disease, the leading cause of death in Americans of all races.

28 Jan 2011

Hand-held PDA devices for recording daily symptoms help fibromyalgia patients: Study

Hand-held PDA devices for recording daily symptoms are helping fibromyalgia patients and their doctors better understand links between pain, emotional distress and fatigue in this complex pain disorder, according to research reported in The Journal of Pain, the peer review publications of the American Pain Society.

28 Jan 2011

CSL Behring receives marketing approval for HAE drug Berinert in Israel

CSL Behring announced today it has been granted national marketing authorization in Israel to market Berinert® for the treatment of acute hereditary angioedema (HAE) attacks in any body location. With this most recent approval, Berinert is now licensed in 30 countries, including Europe, Japan, North America, South America and Australia.

28 Jan 2011

McGill, GSK enter collaborative research agreement on cystic fibrosis

McGill University and GlaxoSmithKline plc have signed a collaboration agreement to develop a potential breakthrough approach to treat cystic fibrosis, a fatal genetic disease. The trans-Atlantic effort between researchers from McGill's Faculty of Medicine and their GSK collaborators in the UK, will focus on developing molecules that could treat the disease by correcting the dysfunction caused by the mutated gene.

28 Jan 2011

Annual mammogram screening at younger age reduces breast cancer deaths

A new study questions the controversial U.S. Preventative Service Task Force recommendations for breast cancer screening, with data that shows starting at a younger age and screening more frequently will result in more lives saved.

28 Jan 2011

Teaming broccoli with sprouts may make vegetable's anti-cancer effect twice as powerful

A new University of Illinois study provides convincing evidence that the way you prepare and consume your broccoli matters, and also suggests that teaming broccoli with broccoli sprouts may make the vegetable's anti-cancer effect almost twice as powerful.

28 Jan 2011

Crossed eyes in adults can also be corrected

Since she was a baby, Carleen Trautz's left eye turned outward, rather than looking straight ahead, and it made her life miserable.

28 Jan 2011

Interim results from ganetespib Phase 2 trial in NSCLC to be presented at 11th IASLC annual meeting

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Dr. Jonathan Goldman, M.D., Premiere Oncology will present interim results from a Phase 2 trial of ganetespib in non-small cell lung cancer at the International Association for the Study of Lung Cancer 11th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.

28 Jan 2011

Discovery of aldose reductase enzyme can result in new therapies for asthma and COPD

Researchers have proved that a single "master switch" enzyme, known as aldose reductase, is key in producing excess mucous that clogs the airways of people with asthma and chronic obstructive pulmonary disease.

28 Jan 2011

Study aims to determine risk of dementia, cognitive decline in middle-aged people

University of North Carolina at Chapel Hill researchers are co-leading a national study to examine whether middle-aged people's physical health influences their risk of dementia later in life.

28 Jan 2011

Boston Scientific reports first U.S. use of Blazer Open-Irrigated Catheter in BLOCk-CTI clinical trial

Boston Scientific Corporation today announced the first use of the Blazer® Open-Irrigated Catheter in the U.S. as part of the BLOCk-CTI clinical trial. BLOCk-CTI is a prospective, randomized trial evaluating the safety and effectiveness of the Blazer Open-Irrigated Catheter in patients with sustained or recurrent Type 1 atrial flutter.

28 Jan 2011

UMMS, Lundbeck enter research collaboration to develop targeted therapy for HD

The University of Massachusetts Medical School and Lundbeck today announced a research collaboration aimed at further development of a targeted therapy to slow or halt the progression of Huntington's disease.

28 Jan 2011

Receptos begins RPC1063 Phase 1 clinical study in patients with multiple sclerosis

Receptos, announced today that their highly selective sphingosine-1-phosphate receptor 1 agonist, RPC1063, has been administered to the first subject in a single-ascending and multiple-ascending dose design Phase 1 clinical safety study.

28 Jan 2011

Medical Condition News

Study identifies gaps in primary health care for seniors with multiple chronic conditions

Study: Running-related injuries increased to 34% in children

Protein Erk necessary for nerve fibers to be wrapped with myelin

Patients and spouses experience distress related to diabetes

XYTOS shares cancer patient treatment results

API2-MALT1 fusion protein appears to trigger cancer

Endo and Orion enter oncology R&D collaboration

Single DNA variation linked to decreased risk of coronary disease in African-Americans

Hand-held PDA devices for recording daily symptoms help fibromyalgia patients: Study

CSL Behring receives marketing approval for HAE drug Berinert in Israel

McGill, GSK enter collaborative research agreement on cystic fibrosis

Annual mammogram screening at younger age reduces breast cancer deaths

Teaming broccoli with sprouts may make vegetable's anti-cancer effect twice as powerful

Crossed eyes in adults can also be corrected

Interim results from ganetespib Phase 2 trial in NSCLC to be presented at 11th IASLC annual meeting

Discovery of aldose reductase enzyme can result in new therapies for asthma and COPD

Study aims to determine risk of dementia, cognitive decline in middle-aged people

Boston Scientific reports first U.S. use of Blazer Open-Irrigated Catheter in BLOCk-CTI clinical trial

UMMS, Lundbeck enter research collaboration to develop targeted therapy for HD

Receptos begins RPC1063 Phase 1 clinical study in patients with multiple sclerosis

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News